Prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: an analysis of 116 cases

Annals of Hematology

Volumn 95, Issue 9, 2016, Pages 1411-1418

  Bin, Qiong ^a   Gao, Jin Hong ^a   Luo, Jian Ming ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Early death; Hemophagocytic lymphohistiocytosis; Outcome; Prognostic factor; Resolution

Indexed keywords

ALBUMIN; ANTIFUNGAL AGENT; BILIRUBIN; CEFOPERAZONE; CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; HEMOGLOBIN; LACTATE DEHYDROGENASE; PIPERACILLIN; SULBACTAM; SERUM ALBUMIN;

ADVERSE OUTCOME; ARTICLE; CHILD; CHINESE; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS INFECTION; EXON; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; MORTALITY; NEUTROPENIA; NEUTROPHIL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT; TREATMENT RESPONSE; ADOLESCENT; BLOOD; INFANT; KAPLAN MEIER METHOD; LIVER; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TIME FACTOR;

ADOLESCENT; BILIRUBIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; LIVER; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MULTIVARIATE ANALYSIS; NEUTROPENIA; OUTCOME ASSESSMENT (HEALTH CARE); PLATELET COUNT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SURVIVAL RATE; TIME FACTORS;

EID: 84974801184     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-016-2727-6     Document Type: Article

References (35)

1. Risma K, Jordan MB (2012) Hemophagocytic lymphohistiocytosis: updates and evolving concepts. Curr Opin Pediatr 24(1):9–15. doi:10.1097/MOP.0b013e32834ec9c1
2. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL (2011) How I treat hemophagocytic lymphohistiocytosis. Blood 118(15):4041–4052. doi:10.1182/blood-2011-03-278127
3. Meeths M, Horne A, Sabel M, Bryceson YT, Henter JI (2014) Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden. Pediatr Blood Cancer. doi:10.1002/pbc.25308
4. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter JI, Bennett M, Fischer A, de Saint Basile G, Kumar V (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286(5446):1957–1959
5. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, Lambert N, Ouachee-Chardin M, Chedeville G, Tamary H, Minard-Colin V, Vilmer E, Blanche S, Le Deist F, Fischer A, de Saint Basile G (2003) Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 115(4):461–473
6. zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, Kabisch H, Schneppenheim R, Nurnberg P, Janka G, Hennies HC (2005) Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 14(6):827–834
7. Cote M, Menager MM, Burgess A, Mahlaoui N, Picard C, Schaffner C, Al-Manjomi F, Al-Harbi M, Alangari A, Le Deist F, Gennery AR, Prince N, Cariou A, Nitschke P, Blank U, El-Ghazali G, Menasche G, Latour S, Fischer A, de Saint Basile G (2009) Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest 119(12):3765–3773. doi:10.1172/JCI40732
8. Yang X, Miyawaki T, Kanegane H (2012) SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis. Pediatr Int 54(4):447–454. doi:10.1111/j.1442-200X.2012.03683.x
9. Trottestam H, Berglof E, Horne A, Onelov E, Beutel K, Lehmberg K, Sieni E, Silfverberg T, Arico M, Janka G, Henter JI (2012) Risk factors for early death in children with haemophagocytic lymphohistiocytosis. Acta Paediatr 101(3):313–318. doi:10.1111/j.1651-2227.2011.02501.x
10. Henter JI, Arico M, Egeler RM, Elinder G, Favara BE, Filipovich AH, Gadner H, Imashuku S, Janka-Schaub G, Komp D, Ladisch S, Webb D (1997) HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 28(5):342–347. doi:10.1002/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H
11. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124–131. doi:10.1002/pbc.21039
12. Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G (2002) Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100(7):2367–2373. doi:10.1182/blood-2002-01-0172
13. Imashuku S, Hibi S, Kuriyama K, Tabata Y, Hashida T, Iwai A, Kato M, Yamashita N, Oda MM, Kinugawa N, Sawada M, Konno M (2000) Management of severe neutropenia with cyclosporin during initial treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Leuk Lymphoma 36(3–4):339–346. doi:10.3109/10428190009148855
14. Imashuku S (2002) Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44(3):259–272
15. Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, Sako M, Hibi S (2001) Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 19(10):2665–2673
16. Trottestam H, Horne A, Arico M, Egeler RM, Filipovich AH, Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, Henter JI (2011) Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 118(17):4577–4584. doi:10.1182/blood-2011-06-356261
17. Imashuku S, Kuriyama K, Sakai R, Nakao Y, Masuda S, Yasuda N, Kawano F, Yakushijin K, Miyagawa A, Nakao T, Teramura T, Tabata Y, Morimoto A, Hibi S (2003) Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol 41(2):103–109. doi:10.1002/mpo.10314
18. Koh KN, Im HJ, Chung NG, Cho B, Kang HJ, Shin HY, Lyu CJ, Yoo KH, Koo HH, Kim HJ, Baek HJ, Kook H, Yoon HS, Lim YT, Kim HS, Ryu KH, Seo JJ (2015) Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party. Eur J Haematol 94(1):51–59. doi:10.1111/ejh.12399
19. De-The G (1981) The Chinese epidemiological approach of nasopharyngeal carcinoma research and control. Yale J Biol Med 54(1):33–39
20. Imashuku S, Teramura T, Kuriyama K, Kitazawa J, Ito E, Morimoto A, Hibi S (2002) Risk of etoposide-related acute myeloid leukemia in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Int J Hematol 75(2):174–177
21. Kaito K, Kobayashi M, Katayama T, Otsubo H, Ogasawara Y, Sekita T, Saeki A, Sakamoto M, Nishiwaki K, Masuoka H, Shimada T, Yoshida M, Hosoya T (1997) Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 59(4):247–253
22. Yu JT, Wang CY, Yang Y, Wang RC, Chang KH, Hwang WL, Teng CL (2013) Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution. Ann Hematol 92(11):1529–1536. doi:10.1007/s00277-013-1784-3
23. Xue H, Chen C, Li W, Lin C, Fang J, Li Y, Xu H (2015) Analysis of prognostic risk factors in children with Epstein-Barr virus-associated hemophagocytic syndrome. Minerva Pediatr 67(3):251–261
24. Park HS, Kim DY, Lee JH, Kim SD, Park YH, Lee JS, Kim BY, Jeon M, Kang YA, Lee YS, Seol M, Lee YJ, Lim YS, Jang S, Park CJ, Chi HS, Lee KH (2012) Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors. Ann Hematol 91(6):897–904. doi:10.1007/s00277-011-1380-3
25. Horne A, Trottestam H, Arico M, Egeler RM, Filipovich AH, Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, Henter JI (2008) Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis. Br J Haematol 140(3):327–335
26. Kim MM, Yum MS, Choi HW, Ko TS, Im HJ, Seo JJ, Koh KN (2012) Central nervous system (CNS) involvement is a critical prognostic factor for hemophagocytic lymphohistiocytosis. Korean J Hematol 47(4):273–280. doi:10.5045/kjh.2012.47.4.273
27. Lin TF, Ferlic-Stark LL, Allen CE, Kozinetz CA, McClain KL (2011) Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer 56(1):154–155. doi:10.1002/pbc.22774
28. Otrock ZK, Eby CS (2015) Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol 90(3):220–224. doi:10.1002/ajh.23911
29. Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, Dupond JL, Larroche C, Piette AM, Mechenstock D, Ziza JM, Arlaud J, Labussiere AS, Desvaux A, Baty V, Blanche P, Schaeffer A, Piette JC, Guillevin L, Boissonnas A, Christoforov B (2003) Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 49(5):633–639. doi:10.1002/art.11368
30. Li F, Yang Y, Jin F, Dehoedt C, Rao J, Zhou Y, Li P, Yang G, Wang M, Zhang R (2015) Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China. Orphanet J Rare Dis 10:20. doi:10.1186/s13023-015-0224-y
31. Li J, Wang Q, Zheng W, Ma J, Zhang W, Wang W, Tian X (2014) Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore) 93(2):100–105. doi:10.1097/MD.0000000000000022
32. Arca M, Fardet L, Galicier L, Riviere S, Marzac C, Aumont C, Lambotte O, Coppo P (2015) Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol 168(1):63–68. doi:10.1111/bjh.13102
33. Zoller EE, Lykens JE, Terrell CE, Aliberti J, Filipovich AH, Henson PM, Jordan MB (2011) Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med 208(6):1203–1214. doi:10.1084/jem.20102538
34. Wang Y, Wang Z, Wu L, Zhang J, Wang J, Yan L (2013) Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis. Ann Hematol 92(12):1695–1699. doi:10.1007/s00277-013-1819-9
35. Zhizhuo H, Junmei X, Yuelin S, Qiang Q, Chunyan L, Zhengde X, Kunling S (2012) Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 58(3):410–414. doi:10.1002/pbc.23216